Skip to content

Public FDA record

Z-0626-03: Misys Laboratory System versions 5.2, 5.23 and 5.3

Recall record Z-0626-03 for Misys Healthcare Systems. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0626-03
Company in FDA record
Misys Healthcare Systems
FDA classification date
Mar 6, 2003
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Software anomaly. Patient results may be filed in the incorrect patient file

Source facts

Action
Notice of the correction was made by Fax on 1/31/2003. The notice indicated a procedural workaround to prevent the occurance of the defect. Corrections will be made to the software at only affected sites. These have been instructed to contact Applications Interface to schedule correction of the interface.
Initiated
2003-01-31
Root cause
Other
Terminated
2004-07-14
Distribution
Nationwide and to United Kingdom, Ireland, Belgium, Canada, Denmark, Bermuda, Saudi Arabia, United Arab Emirates,
Recall number
Z-0626-03
Recall status
Terminated
CDRH record ID
26041
FDA classified
2003-03-06
Recall event number
25557

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗